Publications

Department of Medicine faculty members published more than 3,600 peer-reviewed articles in 2024.

Filter by

Journal of the National Comprehensive Cancer Network : JNCCN

It's About Time!

2017

Authors: Tempero M

Circulation. Arrhythmia and electrophysiology

Pharmacologic Prevention of Incident Atrial Fibrillation: Long-Term Results From the ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).

2017

Authors: Dewland TA, Soliman EZ, Yamal JM, Davis BR, Alonso A, Albert CM, Simpson LM, Haywood LJ, Marcus GM

Medical care

Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.

2017

Authors: Fang MC, Fan D, Sung SH, Witt DM, Schmelzer JR, Steinhubl SR, Yale SH, Go AS

JAMA internal medicine

Using Spatial and Temporal Mapping to Identify Nosocomial Disease Transmission of Clostridium difficile.

2017

Authors: Murray SG, Yim JWL, Croci R, Rajkomar A, Schmajuk G, Khanna R, Cucina RJ

Volume 92 of Issue 12 | Academic medicine : journal of the Association of American Medical Colleges

What Are the Opportunity Costs of Self-Financing Medical Education?

2017

Authors: Nguyen OK, Makam AN

Volume 86 of Issue 6 | Gastrointestinal endoscopy

ERCP: Time to take the lead off?

2017

Authors: Binmoeller KF, Nett A

The American journal of tropical medicine and hygiene

"The Way We Were" Ken Warren's Legacy and Modern Investments in Global Health.

2017

Authors: Panosian C, Rosenthal PJ

Neurosurgery

Analysis of Cost Variation in Craniotomy for Tumor Using 2 National Databases.

2017

Authors: Zygourakis CC, Liu CY, Yoon S, Moriates C, Boscardin C, Dudley RA, Lawton MT, Theodosopoulos P, Berger MS, Gonzales R

Volume 21 of Issue 12 | AIDS and behavior

Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men.

2017

Authors: Carballo-Diéguez A, Giguere R, Dolezal C, Leu CS, Balán IC, Brown W, Rael C, Richardson BA, Piper JM, Bekker LG, Chariyalertsak S, Chitwarakorn A, Gonzales P, Holtz TH, Liu A, Mayer KH, Zorrilla CD, Lama JR, McGowan I, Cranston RD

View Abstract

Oral pre-exposure prophylaxis (PrEP) can prevent HIV transmission. Yet, some may prefer not to take systemic daily medication. MTN-017 was a 3-period, phase 2 safety and acceptability study of microbicide gel applied rectally either daily or before and after receptive anal intercourse (RAI), compared to daily oral tablet. At baseline, cisgender men and transgender women who reported RAI (N = 187) rated the daily oral regimen higher in overall liking, ease of use, and likelihood of future use than the gel regimens. After trying all three, 28% liked daily oral the least. Gel did not affect sexual enjoyment (88%) or improved it (7-8%). Most partners had no reaction to gel use. Ease of gel use improved significantly between the first and the last few times of daily use. A rectal gel used before and after RAI may constitute an attractive alternative to daily tablet. Experience with product use may increase acceptability.

View on PubMed

AIDS and behavior

Association between Perceived Discrimination in Healthcare Settings and HIV Medication Adherence: Mediating Psychosocial Mechanisms.

2017

Authors: Turan B, Rogers AJ, Rice WS, Atkins GC, Cohen MH, Wilson TE, Adimora AA, Merenstein D, Adedimeji A, Wentz EL, Ofotokun I, Metsch L, Tien PC, Johnson MO, Turan JM, Weiser SD